CIBC World Market
TGTX icon

CIBC World Market’s TG Therapeutics TGTX Stock Holding History

CIBC World Market’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-9,243
Closed -$364K – 1472
2025
Q1 		$364K Buy
+9,243
New +$311K ﹤0.01% 1116
2021
Q4 		– Sell
-6,500
Closed -$216K – 1420
2021
Q3 		$216K Hold
6,500
– – ﹤0.01% 1239
2021
Q2 		$252K Hold
6,500
– – ﹤0.01% 1200
2021
Q1 		$313K Hold
6,500
– – ﹤0.01% 1083
2020
Q4 		$338K Buy
+6,500
New +$220K ﹤0.01% 1053
2018
Q3 		– Sell
-26,800
Closed -$352K – 1234
2018
Q2 		$352K Sell
26,800
-6,650
-20% -$91.5K ﹤0.01% 929
2018
Q1 		$475K Buy
33,450
+3,000
+10% +$38.3K ﹤0.01% 864
2017
Q4 		$250K Buy
+30,450
New +$266K ﹤0.01% 703

Other funds holding TGTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CIBC World Market's TGTX Position: Q2 2025 in Review

CIBC World Market sold out of TG Therapeutics (TGTX) in Q2 2025, closing a stake of 9,243 shares — an estimated $364K sold.

CIBC World Market first reported a position in TGTX in Q4 2017 and held it in 8 quarters. The position peaked at $475K in Q1 2018. 356 funds tracked by Wall St. Rank hold TGTX as of Q2 2025.

  • CIBC World Market reported no remaining TG Therapeutics position as of Q2 2025 after selling out during the quarter.
  • CIBC World Market sold 9,243 TG Therapeutics shares in Q2 2025, an estimated $364K.
  • CIBC World Market first reported a position in TG Therapeutics in Q4 2017 and held it in 8 quarters.
  • CIBC World Market's TG Therapeutics position peaked at $475K in Q1 2018.
  • 356 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2025.

Based on CIBC World Market's 13F filing for Q2 2025, filed 14 Aug 2025.